company background image
AKU

AkuminTSX:AKU Stock Report

Market Cap

CA$186.1m

7D

-5.2%

1Y

-52.6%

Updated

01 Dec, 2021

Data

Company Financials +
AKU fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

AKU Stock Overview

Akumin Inc. provides outpatient diagnostic imaging services in the United States.

Akumin Competitors

Universal Health Services

NYSE:UHS

US$9.5b

Encompass Health

NYSE:EHC

US$5.7b

Acadia Healthcare Company

NasdaqGS:ACHC

US$5.1b

Surgery Partners

NasdaqGS:SGRY

US$3.9b

Price History & Performance

Summary of all time highs, changes and price drops for Akumin
Historical stock prices
Current Share PriceCA$1.99
52 Week HighCA$4.98
52 Week LowCA$1.95
Beta1.09
1 Month Change-8.30%
3 Month Change-37.22%
1 Year Change-52.62%
3 Year Change-56.74%
5 Year Changen/a
Change since IPO-59.39%

Recent News & Updates

May 14
Akumin (TSE:AKU) Use Of Debt Could Be Considered Risky

Akumin (TSE:AKU) Use Of Debt Could Be Considered Risky

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

AKUCA HealthcareCA Market
7D-5.2%-3.9%-3.7%
1Y-52.6%-7.6%20.6%

Return vs Industry: AKU underperformed the Canadian Healthcare industry which returned -6.7% over the past year.

Return vs Market: AKU underperformed the Canadian Market which returned 23.7% over the past year.

Price Volatility

Is AKU's price volatile compared to industry and market?
AKU volatility
AKU Average Weekly Movement10.7%
Healthcare Industry Average Movement9.2%
Market Average Movement9.4%
10% most volatile stocks in CA Market17.3%
10% least volatile stocks in CA Market3.5%

Stable Share Price: AKU is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: AKU's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,737Riadh Zine Zine-El-Abidinehttps://www.akumin.com

Akumin Inc. provides outpatient diagnostic imaging services in the United States. Its centers offer physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The company provides various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures; and online medical bill payment services.

Akumin Fundamentals Summary

How do Akumin's earnings and revenue compare to its market cap?
AKU fundamental statistics
Market CapUS$145.35m
Earnings (TTM)-US$19.79m
Revenue (TTM)US$264.43m

0.5x

P/S Ratio

-7.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AKU income statement (TTM)
RevenueUS$264.43m
Cost of RevenueUS$185.13m
Gross ProfitUS$79.30m
ExpensesUS$99.09m
Earnings-US$19.79m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.22
Gross Margin29.99%
Net Profit Margin-7.48%
Debt/Equity Ratio591.8%

How did AKU perform over the long term?

See historical performance and comparison

Valuation

Is Akumin undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AKU (CA$1.99) is trading below our estimate of fair value (CA$12.53)

Significantly Below Fair Value: AKU is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AKU is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.

PE vs Market: AKU is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AKU's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AKU is good value based on its PB Ratio (1.8x) compared to the CA Healthcare industry average (2.5x).


Future Growth

How is Akumin forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

39.2%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AKU's forecast earnings growth is above the savings rate (1.6%).

Earnings vs Market: Insufficient data to determine if AKU's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AKU's revenue (39.2% per year) is forecast to grow faster than the Canadian market (5.6% per year).

High Growth Revenue: AKU's revenue (39.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AKU's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Akumin performed over the past 5 years?

-34.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AKU is currently unprofitable.

Growing Profit Margin: AKU is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: AKU is unprofitable, and losses have increased over the past 5 years at a rate of 34.2% per year.

Accelerating Growth: Unable to compare AKU's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AKU is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-13.3%).


Return on Equity

High ROE: AKU has a negative Return on Equity (-21.78%), as it is currently unprofitable.


Financial Health

How is Akumin's financial position?


Financial Position Analysis

Short Term Liabilities: AKU's short term assets ($145.6M) exceed its short term liabilities ($53.1M).

Long Term Liabilities: AKU's short term assets ($145.6M) do not cover its long term liabilities ($610.9M).


Debt to Equity History and Analysis

Debt Level: AKU's net debt to equity ratio (497.8%) is considered high.

Reducing Debt: AKU's debt to equity ratio has increased from 476% to 591.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable AKU has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: AKU is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 51.9% per year.


Dividend

What is Akumin current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AKU's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AKU's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AKU's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AKU's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AKU's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average management tenure


CEO

Riadh Zine Zine-El-Abidine (49 yo)

0.17

Tenure

US$2,441,300

Compensation

Mr. Riadh Zine-El-Abidine also known as Riadh Zine, serves as Director at Peraso Technologies Inc. He has been Co-Chief Executive Officer at Akumin Inc. since September 1, 2021 and serves as its Chairman o...


CEO Compensation Analysis

Compensation vs Market: Riadh Zine's total compensation ($USD2.44M) is above average for companies of similar size in the Canadian market ($USD163.63K).

Compensation vs Earnings: Riadh Zine's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: AKU's management team is considered experienced (2 years average tenure).


Board Members

Experienced Board: AKU's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.9%.


Top Shareholders

Company Information

Akumin Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Akumin Inc.
  • Ticker: AKU
  • Exchange: TSX
  • Founded: NaN
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$186.066m
  • Shares outstanding: 89.03m
  • Website: https://www.akumin.com

Number of Employees


Location

  • Akumin Inc.
  • 8300 West Sunrise Boulevard
  • Plantation
  • Florida
  • 33322
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/01 00:13
End of Day Share Price2021/11/30 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.